Company intelligence / Profile preview

Vektor Pharma

North Rhine-Westphalia, Germany6sense.com ↗

Ownership: Private
Employees: ~26
Development stage: Other

Overview

Vektor Pharma has developed novel transdermal systems and oral/sublingual films for efficient drug delivery. Several programs have passed pilot pharmacokinetic studies, with clinical trials planned or underway targeting indications such as Parkinson’s disease, epilepsy, anorexia/nausea, and multiple sclerosis-associated spasticity.

Therapeutic areas: GastroenterologyNeurology
Modalities: Transdermal patchOral dissolvable film
Industry: Biotech

Partnerships

BioNxt Solutions

Beyond the preview

Go deeper on Vektor Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vektor Pharma.

Explore the full profile